HemaSphere (Aug 2023)

P1253: REDUCED EXPRESSION OF THE CHEMOKINES CXCL2, CXCL3 AND CXCL8 PROVIDES A POTENTIAL MECHANISM PROMOTING IMMUNE EVASION FACILITATING AML RELAPSE FOLLOWING ALLOGENEIC HSCT

Sarah Charrot,
Jennifer Ball,
Findlay Copley,
James Aries,
Matthew Mee,
Symeon Theocharidis,
James Heward,
John Gribben,
Jeff Davies

Affiliations

Sarah Charrot: 1 Barts Cancer Institute, United Kingdom
Jennifer Ball: 1 Barts Cancer Institute, United Kingdom
Findlay Copley: 1 Barts Cancer Institute, United Kingdom
James Aries: 1 Barts Cancer Institute, United Kingdom
Matthew Mee: 1 Barts Cancer Institute, United Kingdom
Symeon Theocharidis: 1 Barts Cancer Institute, United Kingdom
James Heward: 1 Barts Cancer Institute, United Kingdom
John Gribben: 1 Barts Cancer Institute, United Kingdom
Jeff Davies: 1 Barts Cancer Institute, United Kingdom

DOI: https://doi.org/10.1097/01.HS9.0000971900.04357.80
Journal volume & issue: Vol. 7
p. e0435780

Abstract

No abstracts available.

Published in HemaSphere

ISSN: 2572-9241 (Online)
Publisher: Wiley
Country of publisher: United States
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
Website: https://onlinelibrary.wiley.com/journal/25729241

About the journal